Advances in Therapeutic Applications of Extracellular Vesicles
DOI: https://doi.org/10.2147/IJN.S409588
IF: 7.033
2023-06-16
International Journal of Nanomedicine
Abstract:Yiming Zhang, 1, 2, &ast Yiming Dou, 1, 2, &ast Yang Liu, 1, 2 Mingyuan Di, 1, 2 Hanming Bian, 1, 2 Xun Sun, 1, 2 Qiang Yang 1, 2 1 Department of Spine Surgery, Tianjin Hospital, Tianjin University, Tianjin, People's Republic of China; 2 Clinical School of Orthopedics, Tianjin Medical University, Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xun Sun; Qiang Yang, Department of Spine Surgery, Tianjin Hospital, 406 Jiefang SouthRoad, Hexi District, Tianjin, 300211, People's Republic of China, Email ; Extracellular vesicles (EVs) are nanoscale bilayer phospholipid membrane vesicles released by cells. Contained large molecules such as nucleic acid, protein, and lipid, EVs are an integral part of cell communication. The contents of EVs vary based on the cell source and play an important role in both pathological and physiological conditions. EVs can be used as drugs or targets in disease treatment, and changes in the contents of EVs can indicate the progression of diseases. In recent years, with the continuous exploration of the structure, characteristics, and functions of EVs, the potential of engineered EVs for drug delivery and therapy being constantly explored. This review provides a brief overview of the structure, characteristics and functions of EVs, summarizes the advanced application of EVs and outlook on the prospect of it. It is our hope that this review will increase understanding of the current development of medical applications of EVs and help us overcome future challenges. Keywords: extracellular vesicle, nanotherapeutic, disease diagnosis, engineered exosome, advances applications Extracellular vesicles (EVs) were originally described as a general term for all extracellular particles of unknown origin. 1 Although evidence of their existence has been available for more than 80 years, it is only in recent decades that research into their production, function, and potential application has begun to emerge. Early studies on EVs received little attention from scientists, and EVs were generally regarded as a waste product of cell metabolism. 2 In 1987, Rose M. Johnstone defined a material produced by the release pathway of polyvesicles after fusion with the cell membrane as exosomes. At the time, exosomes were believed to be just a type of "garbage can". 3,4 Later, a breakthrough was made in the study of the outer membrane of cells. Scientists found that the function of exosomes was not limited to the transport of metabolic waste. For example, exosomes have enzyme activities that promote blood clotting and antigen presentation, and there is interaction between bacteria-derived exosomes and human intestinal cells. 5,6 Among them, exosomes, play the most important role in anti-tumor immunity. Dendritic cell-derived exosomes (Dex) can carry cancer cell antigens and be utilized for tumor treatment, which has been verified by clinical experiments. 7 Since then, the field of EVs has gradually gained the attention in the fields of cell biology and biotechnology, especially has experienced rapid development in the past 20 years. 8 In 2018, the International Extracellular Vesicle Association (ISEV) published the Minimal Information for Studies of Extracellular Vesicles (MISEV 2018) to better isolate and classify different types of EVs. It provides a reference and research paradigm for EVs research. 9 Figure 1 Brief overview of the structure, characteristics and functions of EVs. Figure 2 Advanced application of EVs. A. Direct therapeutic B. Indirect therapeutic C. Block EVs associated with diseases D. Block the uptake of EVs associated with diseases E. Physical elimination of EVs associated with diseases F. Engineered EVs: drug delivery G. Engineered EVs: Internal modification H. Engineered EVs: parent cell surface modification I. Engineered EVs: EVs surface modification. In recent years, there has been an increasing clarity in understanding the relationship between the components of EVs from different cell sources and their biological functions. Meanwhile, advancements in click chemistry and biological orthogonal technology have led to a surge in application studies that focus on EV components and biological characteristics. The applications can be roughly divided into the following three classes based on their basis: 1. Application based on EVs' biological function (pure application, treatment or blocking). 2. Applications based on EVs' biological properties (membrane structure, engineered exosomes). 3. Applications based on the relationship bet -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology